Canon Presents Information on Genetic Diagnostics and Screening Using Microfluidics Technology
Complete the form below to unlock access to ALL audio articles.
Canon U.S.A., Inc., has announced that Canon U.S. Life Sciences, Inc., is using Caliper Life Sciences’ LabChip microfluidics technology and industry techniques in an effort to help develop future genetic diagnostic and screening solutions.
Information will be presented at the 10th International Conference on Miniaturized Systems for Chemistry and Life Sciences (MicroTAS2006) in Tokyo, November 6th - 9th.
Canon U.S. Life Sciences is seeking to leverage Caliper’s microfluidics technology and industry thermal melting analysis techniques to shorten the processing time, lower the cost of gene diagnosis, and enable review of genes in clinical environments.
In addition, the microfluidics technology is based on the manipulation of nanoliter size volumes of patient samples to amplify genes, and the thermal melting analysis techniques use thermal energy to identify small differences in specific genes.
"More efficient and precise genetic screening will be an essential part of the future medical diagnosis market," said Takayoshi Hanagata, chairman and chief executive officer, Canon U.S. Life Sciences, Inc.
"Working with technologies like Caliper’s, Canon is seeking to design and develop quality genetic diagnosis innovations that will help physicians to rapidly diagnose genes to help identify and treat potential genetic disorders or abnormalities."
